Cargando…
Clinical Impact of ACE-I/ARB for Conservatively Treated Patients with Moderate to Severe Mitral Regurgitation: A Single Center Observational Study
(1) Background: Mitral regurgitation (MR) is associated with increased mortality and frequent hospital admissions. Although mitral valve intervention offers improved clinical outcomes for MR, it is not feasible in many cases. Moreover, conservative therapeutic opportunities remain limited. The aim o...
Autores principales: | Uzel, Robert, Bruno, Raphael R., Jung, Christian, Lang, Christian, Hoi, Hannes, Grünbart, Martin, Datz, Christian, Hoppichler, Friedrich, Wernly, Bernhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142284/ https://www.ncbi.nlm.nih.gov/pubmed/37103056 http://dx.doi.org/10.3390/jcdd10040177 |
Ejemplares similares
-
Frailty as a predictor of mortality and readmission rate in secondary mitral regurgitation
por: Uzel, Robert, et al.
Publicado: (2023) -
The impact of gender and frailty on the outcome of older patients with functional mitral regurgitation
por: Bruno, Raphael Romano, et al.
Publicado: (2023) -
ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs
por: Lee, Ivan T., et al.
Publicado: (2020) -
Mapping of mitral regurgitant defects by cardiovascular magnetic resonance in moderate or severe mitral regurgitation secondary to mitral valve prolapse
por: Gabriel, Ruvin S, et al.
Publicado: (2008) -
Acquired von Willebrand syndrome and factor VIII in patients with moderate to severe mitral regurgitation undergoing transcatheter mitral valve repair
por: Meindl, Christine, et al.
Publicado: (2020)